Literature DB >> 13635024

Depression of norepinephrine and 5-hydroxytryptamine in the brain by benzoquinolizine derivatives.

A PLETSCHER, H BESENDORF, K F GEY.   

Abstract

The effects of two benzoquinolizine derivatives on the 5-hydroxytryptamine and norepinephrine content of the brain of mice, and some pharmacological actions, are described. Certain central effects (such as sedation and narcosis potentiation) of benzoquinolizine derivatives and possibly of Rauwolfia alkaloids may be due to changes of norepinephrine metabolism rather than to changes of 5-hydroxytryptamine metabolism in the brain.

Entities:  

Keywords:  ARTERENOL/metabolism; BRAIN/metabolism; HETEROCYCLIC COMPOUNDS/effects; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1959        PMID: 13635024     DOI: 10.1126/science.129.3352.844

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  2 in total

1.  Blockade of central 5-hydroxytryptamine receptors by methiothepin.

Authors:  M A Monachon; W P Burkard; M Jalfre; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

Review 2.  L-dopa therapy in Parkinson's disease: a critical review of nine years' experience.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1969-12-27       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.